<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Guidelines Archives - ITPC MENA</title>
	<atom:link href="https://itpcmena.org/language/en/category/guidelines/feed/" rel="self" type="application/rss+xml" />
	<link>https://itpcmena.org/language/en/category/guidelines/</link>
	<description>International Treatment Preparedness Coalition</description>
	<lastBuildDate>Tue, 25 Apr 2023 10:48:09 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://i0.wp.com/itpcmena.org/wp-content/uploads/2016/01/cropped-logo-ITPC-MENA-HAUTE-DEF-1-1.png?fit=32%2C32&#038;ssl=1</url>
	<title>Guidelines Archives - ITPC MENA</title>
	<link>https://itpcmena.org/language/en/category/guidelines/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">123726864</site>	<item>
		<title>New Study: The Impact of the COVID-19 Health Crisis on Access to HIV Services in Egyp…</title>
		<link>https://itpcmena.org/language/en/new-study-the-impact-of-the-covid-19-health-crisis-on-access-to-hiv-services-in-egypt-morocco-mauritania-and-tunisia/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Tue, 25 Apr 2023 10:46:38 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Egypt]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HCV]]></category>
		<category><![CDATA[Health Financing]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Morocco]]></category>
		<category><![CDATA[North Africa]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Tunisia]]></category>
		<guid isPermaLink="false">https://itpcmena.org/?p=9187</guid>

					<description><![CDATA[<p>A study was carried out by the FORSS consortium which includes (ITPC-MENA, Solidarité SIDA, AGD, ATP+, Al Shehab RdR Maroc, and M-Coalition). This recently developed report analyzes the impact of the COVID-19 pandemic on HIV-related health services in the MENA region, specifically in four countries in the region, namely (Egypt, Mauritania, Morocco, and Tunisia). ). [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/new-study-the-impact-of-the-covid-19-health-crisis-on-access-to-hiv-services-in-egypt-morocco-mauritania-and-tunisia/">New Study: The Impact of the COVID-19 Health Crisis on Access to HIV Services in Egyp…</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">9187</post-id>	</item>
		<item>
		<title>Civil Society Speaks: Fighting for Universal Access To Dolutegravir (DTG)!</title>
		<link>https://itpcmena.org/language/en/civil-society-speaks-fighting-for-universal-access-to-dolutegravir-dtg/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Fri, 16 Feb 2018 17:50:28 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=3421</guid>

					<description><![CDATA[<p>Source : The Global Network of People living with HIV GNP+ What do people living with HIV need to know about Dolutegravir? What do our communities need to know about viral resistance to first line ARVs? GNP+ invites you to an important treatment access discussion on accelerating the roll out of Dolutegravir, a groundbreaking alternative [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/civil-society-speaks-fighting-for-universal-access-to-dolutegravir-dtg/">Civil Society Speaks: Fighting for Universal Access To Dolutegravir (DTG)!</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3421</post-id>	</item>
		<item>
		<title>A new victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on A…</title>
		<link>https://itpcmena.org/language/en/a-new-victory-for-itpc-mena-bristol-myers-squibb-extends-its-voluntary-license-on-atazanavir-to-egypt/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Tue, 25 Jul 2017 18:18:19 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[Algeria]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Intellectual Proprety]]></category>
		<category><![CDATA[Medias]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Morocco]]></category>
		<category><![CDATA[North Africa]]></category>
		<category><![CDATA[Tunisia]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=3019</guid>

					<description><![CDATA[<p>The 9th International AIDS Society Conference on HIV / AIDS 2017 : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt, a victory for ITPC-MENA Today, at the World Conference on AIDS, which is currently taking place in Paris from the 23rd to 26th July 2017, Bristol-Myers Squibb (BMS) and the Medicines Patent Pool [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/a-new-victory-for-itpc-mena-bristol-myers-squibb-extends-its-voluntary-license-on-atazanavir-to-egypt/">A new victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on A…</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3019</post-id>	</item>
		<item>
		<title>BLOG: We want dolutegravir for all, and we want it now</title>
		<link>https://itpcmena.org/language/en/blog-we-want-dolutegravir-for-all-and-we-want-it-now/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Tue, 25 Jul 2017 12:03:19 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Dolutegravir]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[North Africa]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=3026</guid>

					<description><![CDATA[<p>Source: makemedicinesaffordable Author: Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC). Article first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to be enacted simultaneously in an initial six countries, in order to get essential treatment to all [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/blog-we-want-dolutegravir-for-all-and-we-want-it-now/">BLOG: We want dolutegravir for all, and we want it now</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">3026</post-id>	</item>
		<item>
		<title>ITPC MENA IN THE REGIONAL CONSULTATION ON ACCELERATING ACCESS TO THE CONTIUUM OF HIV …</title>
		<link>https://itpcmena.org/language/en/itpc-mena-in-the-regional-consultation-on-accelerating-access-to-the-contiuum-of-hiv-care-focus-on-hiv-testing/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Fri, 21 Jul 2017 17:31:11 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Daclatasvir]]></category>
		<category><![CDATA[Dolutegravir]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Morocco]]></category>
		<category><![CDATA[North Africa]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=2973</guid>

					<description><![CDATA[<p>Beirut, Lebanon, 12–14 July 2017 By the end of 2015, the estimated number of people living with HIV in the Region had reached 330 000. With a continuously growing epidemic coupled with low coverage of ART, standing at 14% of people living with HIV, the number of deaths among people living with HIV was 15 [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/itpc-mena-in-the-regional-consultation-on-accelerating-access-to-the-contiuum-of-hiv-care-focus-on-hiv-testing/">ITPC MENA IN THE REGIONAL CONSULTATION ON ACCELERATING ACCESS TO THE CONTIUUM OF HIV …</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2973</post-id>	</item>
		<item>
		<title>New WHO Guidance Report- Treatment Failure and Drug Resistance</title>
		<link>https://itpcmena.org/language/en/new-who-guidance-report-treatment-failure-and-drug-resistance/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Thu, 20 Jul 2017 16:54:35 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Daclatasvir]]></category>
		<category><![CDATA[Dolutegravir]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[The Global Fund]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=2970</guid>

					<description><![CDATA[<p>WHO urges action against HIV drug resistance threat 20 JULY 2017 &#124; GENEVA &#8211; WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/new-who-guidance-report-treatment-failure-and-drug-resistance/">New WHO Guidance Report- Treatment Failure and Drug Resistance</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2970</post-id>	</item>
		<item>
		<title>The HepC Pill Bill</title>
		<link>https://itpcmena.org/language/en/the-hepc-pill-bill/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Wed, 05 Apr 2017 10:44:03 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HCV]]></category>
		<category><![CDATA[Hepatitis]]></category>
		<category><![CDATA[Sofosbuvir]]></category>
		<guid isPermaLink="false">http://itpcmena.org/dev/itpc-mena/?p=2820</guid>

					<description><![CDATA[<p>Source : hepCoalition The HepC Pill Bill-An insight into the availability, pricing and accessibility of HCV treatment Introduction to Direct Acting Antivirals Hepatitis C treatment has remarkably evolved over the years. The previously known standard HCV regimen consisted of a course of pegylated interferon injections and ribavirin tablets, which all in all were expensive, toxic, [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/the-hepc-pill-bill/">The HepC Pill Bill</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2820</post-id>	</item>
		<item>
		<title>Building Capacity on Intellectual Property, Free Trade Agreement and Access to Medici…</title>
		<link>https://itpcmena.org/language/en/building-capacity-on-intellectual-property-free-trade-agreement-and-access-to-medicines-workshop/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Fri, 20 Nov 2015 11:42:19 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[ALECA]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HCV]]></category>
		<category><![CDATA[Health Financing]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Intellectual Proprety]]></category>
		<category><![CDATA[North Africa]]></category>
		<category><![CDATA[Tunisia]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=2920</guid>

					<description><![CDATA[<p>ATL MST – ITPC MENA WORKSHOP TUNISIA 16, 17 &#38; 18 NOVEMBER 2015 One of the most pressing issues in the 21st century is the lack of availability of essential medicines to poor patients in underdeveloped and developing countries. The problem is attributed to the existing Intellectual Property Rights (IPR) regimes, which were not aligned [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/building-capacity-on-intellectual-property-free-trade-agreement-and-access-to-medicines-workshop/">Building Capacity on Intellectual Property, Free Trade Agreement and Access to Medici…</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2920</post-id>	</item>
		<item>
		<title>WHO Launches New HIV Treatment and Prevention Guidelines</title>
		<link>https://itpcmena.org/language/en/who-new-treatment-recommendations/</link>
		
		<dc:creator><![CDATA[detrich]]></dc:creator>
		<pubDate>Wed, 14 Oct 2015 15:08:18 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[guide]]></category>
		<category><![CDATA[WHO]]></category>
		<guid isPermaLink="false">http://itpcmena.org/dev/itpc-mena/?p=2411</guid>

					<description><![CDATA[<p>The WHO has made two important new treatment recommendations that will affect all HIV treatment programmes. The recommendations are entitled the ’Early Release’ Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. The recommendations in this guideline will form part of the revised consolidated guidelines on the use of ARV drugs [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/who-new-treatment-recommendations/">WHO Launches New HIV Treatment and Prevention Guidelines</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2411</post-id>	</item>
		<item>
		<title>The first Middle East and North Africa Community Advisory Board (MENA-CAB)</title>
		<link>https://itpcmena.org/language/en/the-first-middle-east-and-north-africa-community-advisory-board-mena-cab/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Thu, 10 Jul 2014 12:18:11 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[Algeria]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Daclatasvir]]></category>
		<category><![CDATA[Dolutegravir]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Intellectual Proprety]]></category>
		<category><![CDATA[Libya]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Morocco]]></category>
		<category><![CDATA[North Africa]]></category>
		<category><![CDATA[REGION]]></category>
		<category><![CDATA[Tunisia]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=2924</guid>

					<description><![CDATA[<p>Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population, the rate of increase of new cases since 2001 makes this region home to one of the most fastest-growing epidemic in the [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/the-first-middle-east-and-north-africa-community-advisory-board-mena-cab/">The first Middle East and North Africa Community Advisory Board (MENA-CAB)</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2924</post-id>	</item>
	</channel>
</rss>
